Ben Stevens
Ben is the editor of Business of Cannabis. Since 2021, he has researched, written, and published the vast majority of the outlet’s content, delivering agenda-setting journalism on regulation, business strategy, and policy across Europe.
Ben Stevens · page 120
- Markets & Stocks
Intercure Counter-Sued By Better, Cantourage Sees Stock Jump 30%, & Tikun Olam Cannbit To Be Acquired
Cantourage [stock_market_widget type=”chart” template=”basic” color=”#5679FF” assets=”HIGH.F” range=”1mo” interval=”1d” axes=”true” cursor=”true” range_selector=”true” display_currency_symbol=”true” api=”yf”] German-listed cannabis distributor has seen its stock price jump by around 30% this week on the Frankfurt stock exchange.
- Press releases
Medical Cannabis on Prescription APPG appoints a new secretariat and with bold strategy and vision
Volteface and The Medical Cannabis Clinicians Society (MCCS) have been successfully elected as the new secretariat for the medical cannabis APPG – bringing new bold strategy and commitment to working collaboratively with parliament, the industry and patients to improve the UK landscape.
- Companies
Cannabis Maker Zyus Life Sciences to Go Public in Reverse Merger With Oil Producer
Cannabis Maker to Go Public in Reverse Merger With Oil Producer Zyus Life Sciences Inc. has completed a reverse takeover (RTO) of long-standing listed crude oil producer Phoenix Canada Oil.
- Medical
What Does Spain’s Snap Election Mean For Its Long-Awaited Medical Cannabis Industry?
THE highly-anticipated regulation and roll out of a medical cannabis industry in Spain, already over 6 months overdue, is now under threat of being set aside completely.
- Policy & Regulation
Amazon-Owned Twitch Bans Streamers From Promoting Marijuana But Allows Alcohol Branding In Policy Update
Amazon-Owned Twitch Bans Streamers From Promoting Marijuana But Allows Alcohol Branding In Policy Update Twitch, the video game streaming platform owned by Amazon, has unveiled new controversial guidelines which prohibit streamers from being sponsored by cannabis brands or products.
- Medical
£60m Of Investment Pumped Into Jersey Since 2016 From Medical Cannabis Businesses, As Government Pushes Ahead With Development Of New Regulations
JERSEY has raked in up to £60m in investment from medical cannabis businesses since 2016, according to the Channel Islands Economic Development Minister.
- Hemp Industry
New hemp research set to increase carbon capture through cropping
A new research project aims to help UK farmers and growers target Net Zero and build farming resilience through diversifying their arable and forage cropping.
- Adult-Use
New York regulators raid unlicensed marijuana stores, enact new rules
New York regulators raid unlicensed marijuana stores, enact new rules In fresh efforts to clamp down on New York’s 1400 unlicensed cannabis operators, a new ‘multiagency enforcement effort’ has been launched.
- Companies
Danish Medical Cannabis Company Stenocare Announces Swathe Of Updates As It Seeks Fresh Funding
DANISH medical cannabis operator Stenocare has published a flurry of operational updates over the past month as it hopes to raise up to DKK30m in a new rights issue.
- Press releases
CIC calls for overhaul of ‘discriminatory’ cannabis driving laws
The current rules for prescription cannabis patients who drive are potentially ‘discriminatory’, according to a new report from the Cannabis Industry Council (CIC).
- Markets & Stocks
Hellenic Dynamics Sees Stocks Slide On News It Will No Longer Target EU-GMP, DeepVerge Downsizes Core Operations, & Celadon Publishes 2022 Figures
Hellenic Dynamics [stock_market_widget type=”chart” template=”basic” color=”#5679FF” assets=”HELD.L” range=”1mo” interval=”1d” axes=”true” cursor=”true” range_selector=”true” display_currency_symbol=”true” api=”yf”] Hellenic Dynamics has seen its stock drop nearly 40% this week following an announcement that it would no longer be pursuing EU GMP (Good Manufacturing Practice) certification for its facility.
- Press releases
Mamedica & 4C LABS Ltd. Conclude Strategic Agreement For The UK Market
4C LABS Ltd. (the “Company” or “4C LABS Ltd”) is pleased to announce that it has entered into a strategic distribution agreement with MAMEDICA (“Mamedica”), a leading medical cannabis clinic and pharmacy based in London.









